Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Herling, Marco

•

Dearden, Claire

•

Zaja, Francesco

altro

Staber, Philipp B.

2024

journal article

Periodico

BLOOD ADVANCES

Abstract

N/A

DOI

10.1182/bloodadvances.2023012248

WOS

WOS:001185558900001

Archivio

https://hdl.handle.net/11368/3085321

info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85186751245

https://ashpublications.org/bloodadvances/article/8/4/842/506985/Limited-efficacy-for-ibrutinib-and-venetoclax-in-T

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874748/

Diritti

open access

license:creative commons

license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/

FVG url

https://arts.units.it/bitstream/11368/3085321/1/Herling_T-PLL_2024.pdf

Soggetti